Krystal Biotech, Inc. (KRYS)
250.08
-1.60
(-0.64%)
USD |
NASDAQ |
Mar 23, 16:00
250.15
+0.07
(+0.03%)
After-Hours: 20:00
Krystal Biotech Total Assets (Quarterly) : 1.334B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 949.87M |
| Scholar Rock Holding Corp. | 404.27M |
| Alkermes Plc | 2.530B |
| Stoke Therapeutics, Inc. | 418.43M |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.23M |
| Shareholders Equity (Quarterly) | 1.220B |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 9.953 |
| Net Debt Paydown Yield | -0.01% |